ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
25,60
0,06
(0,23%)
Fermé 02 Juillet 10:12PM

Gilead Sciences CDR (GILD) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
25,60
( 0,23% )
Prix Achat
25,52
Prix Vente
25,69
Volume échangé
71 775
25,59 Fourchette du Jour 25,65
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
25,54
Ouverture
25,59
Dernière Transaction
600
@
25.6
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
$ 7 102 941
Actions en circulation
1 241 569 874
Rendement du Dividende (LTM)
3,19 (2,50%)
Ratio Cours sur Bénéfices
17,18
Bénéfice par action (BPA)
7,35
Chiffre d'affairess (LTM)
29,74B
Bénéfice net (LTM)
9,22B

À propos de Gilead Sciences CDR

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California. Show more

Secteur
-
Industrie
-
Site Web
Siège social
Foster City, United States
Fondé
1987
Gilead Sciences CDR est coté dans le secteur de la Toronto Stock Exchange avec le ticker GILD. Le dernier cours de clôture d'Gilead Sciences CDR était de $25,54. Au cours de la dernière année, les actions de Gilead Sciences CDR ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Gilead Sciences CDR compte actuellement 1 241 569 874 actions en circulation. La capitalisation boursière d'Gilead Sciences CDR est de $31,78 milliard. Gilead Sciences CDR a un ratio cours/bénéfice (ratio PE) de 17.18.

GILD Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

GILD - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences CDR share price?
The current share price of Gilead Sciences CDR is $ 25,60
How many Gilead Sciences CDR shares are in issue?
Gilead Sciences CDR has 1 241 569 874 shares in issue
What is the market cap of Gilead Sciences CDR?
The market capitalisation of Gilead Sciences CDR is CAD 31,78B
What is the 1 year trading range for Gilead Sciences CDR share price?
Gilead Sciences CDR has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Gilead Sciences CDR?
The price to earnings ratio of Gilead Sciences CDR is 17,18
What is the cash to sales ratio of Gilead Sciences CDR?
The cash to sales ratio of Gilead Sciences CDR is 5,27
What is the registered address of Gilead Sciences CDR?
The registered address for Gilead Sciences CDR is 333 Lakeside Drive, Foster City, California, 94404
What is the Gilead Sciences CDR website address?
The website address for Gilead Sciences CDR is www.gilead.com

GILD Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock